FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula
,
where: X is a nitrogen or carbon atom; Ar is phenyl or a heteroaromatic ring selected from pyrazolyl, furanyl, thiophenyl and isoxazolyl; R1 is hydrogen, halogen, CN or (C1-C4)alkyl; R2 is halogen or (C1-C3)alkoxy optionally fluorinated with 1-3 fluorine atoms; R3 and R5 independently denote hydrogen, (C1-C4)alkyl, (C1-C4)alkoxy, (C1-C4)alkenyl or hydroxymethyl; R4 is hydrogen, halogen, optionally fluorinated (C1-C4)alkoxy or aryl(C1-C4)alkoxy; R6 is hydrogen, optionally fluorinated (C1-C4)alkyl; each R7 independenlty denotes hydrogen, halogen, optionally fluorinated (C1-C4)alkyl or (C1-C4)alkoxy optionally fluorinated with 1-3 fluorine atoms; or pharmaceutically acceptable acid addition salts thereof. The invention also relates to use of compounds of formula (I) in a pharmaceutical composition and when preparing a medicinal agent meant for treatment, the aim of which is to change the secondary signal activity level after activation of glucocorticoid receptors.
EFFECT: compounds of formula I for changing the secondary signal activity level after activation of glucocorticoid receptors.
7 cl, 5 dwg, 49 ex
| Title | Year | Author | Number |
|---|---|---|---|
| SUBSTITUTED HETEROCYCLIC COMPOUNDS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS, METHOD OF CONTROL OVER WEEDS | 1993 |
|
RU2125050C1 |
| BIARYL- OR HETEROCYCLIC BIARYL-SUBSTITUTED DERIVATIVES OF CYCLOHEXENE AS CETP INHIBITORS | 2014 |
|
RU2627361C2 |
| PYRIDINONE AND PYRIDAZINONE DERIVATIVES | 2012 |
|
RU2632915C2 |
| 2,6-SUBSTUTED-4-MONOSUBSTITUTED AMINO-PYRIMIDINES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS | 2005 |
|
RU2417990C2 |
| THIOUREA DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF REVERSE TRANSCRIPTASE OF AIDS | 1992 |
|
RU2106341C1 |
| SUBSTITUTED ARYLAMINES AND THEIR APPLICATION AS 5-HT-RECEPTOR MODULATORS | 2006 |
|
RU2440996C2 |
| CATHEPSIN-CYSTEINE PROTEASE INHIBITORS | 2003 |
|
RU2312861C2 |
| FGFR4 INHIBITORS | 2014 |
|
RU2715708C2 |
| SERINE PROTEASE INHIBITORS, PHARMACEUTICAL COMPOSITION AND THERAPEUTICAL METHODS BASED ON THE SAME | 2000 |
|
RU2252935C2 |
| NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES USEFUL AS PLASMA KALLIKREIN INHIBITOR | 2014 |
|
RU2712621C2 |
